Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
ERIS Lifesciences LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:540596NSE Symbol: ERISP/E(TTM):300.41
ISIN Demat:INE406M01024Div & Yield %:0.43EPS(TTM):5.68
Book Value(Rs):184.651184Market Cap ( Cr.):23240.03Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 1704.031528.281340.371215.731108.831020.23
Excise Duty0.000.000.000.000.000.00
Net Sales1704.031528.281340.371215.731108.831020.23
Other Income 35.5134.8317.2628.9910.0014.73
Stock Adjustments 43.5413.15-8.50-2.4912.57-17.47
Total Income1783.081576.261349.131242.231131.401017.49
EXPENDITURE :      
Raw Materials 542.79293.31227.88197.16211.08146.88
Power & Fuel Cost4.104.464.414.013.894.54
Employee Cost 361.92331.67252.52220.11207.02191.73
Other Manufacturing Expenses 22.3516.8011.507.477.1610.62
Selling and Administration Expenses 223.80319.27242.67215.51181.66219.34
Miscellaneous Expenses 106.06122.1087.7884.9393.1373.93
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1261.021087.61826.75729.18703.93647.04
Operating Profit522.06488.65522.38513.04427.47370.44
Interest 220.2457.4220.813.050.941.97
Gross Profit301.82431.23501.57509.99426.53368.47
Depreciation181.77102.3964.6651.4637.6444.88
Profit Before Tax120.05328.84436.91458.53388.89323.59
Tax21.9857.6476.5080.1770.1857.49
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax20.68-28.52-37.59-38.83-31.90-25.17
Reported Net Profit77.39299.72398.01417.19350.61291.27
Extraordinary Items 1.352.795.17-1.722.334.49
Adjusted Net Profit76.04296.93392.84418.91348.28286.78
Adjst. below Net Profit -2.84-2.76-0.15-1.01-1.28-100.21
P & L Balance brought forward2487.172190.211892.281557.741283.091139.01
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 100.060.0099.9381.6574.6846.98
P & L Balance carried down2461.662487.172190.211892.281557.741283.09
Dividend0.000.0099.9381.6574.6838.97
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %735.000.00735.00601.00550.00287.00
Earnings Per Share-Unit Curr5.6822.0429.2730.6925.8221.45
Earnings Per Share(Adj)-Unit Curr5.6822.0429.2730.6925.8221.45
Book Value-Unit Curr184.65185.59163.39141.11116.0395.72